Pharma Journalist -

Viralgen and AskBio announced that Viralgen has received Current Good Manufacturing Practices (cGMP) compliance accreditation and Pharmaceutical Laboratory authorization by the AEMPS…
Read More...

Ionis Pharmaceuticals, the leader in RNA-targeted therapeutics, announced today that GSK exercised its option to license Ionis' antisense medicines for people with chronic hepatitis B…
Read More...

Alvotech and Prestige Biopharma announced a new contract manufacturing partnership for one of Prestige Biopharma´s biosimilar candidates. Alvotech’s Contract Services have been…
Read More...

Machavert Pharmaceuticals, a preclinical stage pharmaceutical company focused on precision medicine cancer therapies, announced that it has obtained a full exclusive license on RAL…
Read More...

Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, and Noile-Immune Biotech, Inc., Tokyo, Japan, a biotechnology company focusing on the development of innovative…
Read More...

Bristol-Myers Squibb Company announced that the European Commission (EC) has approved Empliciti (elotuzumab) plus pomalidomide and low-dose dexamethasone (EPd) for the treatment of…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to delay the progression of renal…
Read More...

The U.S. Food and Drug Administration approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD)…
Read More...

The WIRB-Copernicus Group's (WCG) Clinical Services Division introduces Velos eResearch eXpress, an out-of-the-box, cloud-based solution that enables clinical research sites to…
Read More...

Mustang Bio, Inc. announced that it has entered into a license agreement with CSL Behring for the Cytegrity stable producer cell line developed and used by St. Jude Children’s Research…
Read More...